Study on relationship of lipoprotein-associated phospholipase A2 expression and atherosclerosis progression

Li-gang HUANG,Lian-hua LIU,Hang-qi LIU,Mei JIA
DOI: https://doi.org/10.3969/j.issn.1673-713X.2018.02.010
2018-01-01
Abstract:Objective We established atherosclerosis (AS) animal model to study the tendency of lipoprotein-associated phospholipase A2 (Lp-PLA2) variation, and distribution of Lp-PLA2 in vascular tissues. Methods ApoE-deficient mice were randomly divided into two groups, of which control group fed on chow diet, the experimental group fed on high fat diet. Mice were randomly picked up to determine serum Lp-PLA2 and other biomarkers, and the aortas were dissected to be immunohistochemically stained with anti-Lp-PLA2. Results Lp-PLA2 levels in the experimental group were significantly higher than those in control group (P < 0.05). There was also significantly linear correlation between Lp-PLA2 and week-of-birth. Multiple factors analysis showed the equation was Y = 0.767778xLp-PLA2+ 0.000594xTG(r2= 0.89658), which could be used to estimate the progression of cardiovascular and cerebrovascular disease. The results from immunohistochemical staining indicated that early plaque had much less Lp-PLA2 than expanded plaques did. Lp-PLA2 mainly distributed in necrotic cores and around the macrophages. At later stage, a large number of Lp-PLA2 was located under the thinning fibrous cap. Conclusion Compared to traditional risk factors, Lp-PLA2 showes greater relevance to AS, and is also related to plaque vulnerability.
What problem does this paper attempt to address?